Back to All
April 14, 2021

Peter Noymer, PhD

Peter Noymer serves as Executive Chairman of the Board for PyrAmes and brings more than twenty years of experience developing novel pharmaceutical and medical device products from concept through to market.

Previously, Peter was CEO of Kedalion Therapeutics, COO of SteadyMed Therapeutics (acquired by United Therapeutics), and VP of Product R&D for Alexza Pharmaceuticals (acquired by Grupo Ferrer). He has MS and PhD degrees from MIT in Mechanical Engineering and a BSE from Princeton in Mechanical and Aerospace Engineering.